Evidence map›Paper›PMID 40531681›Full record

ArticleMMWR. Morbidity and mortality weekly report2025

Clade Ib Mpox Outbreak - Kenya, July 2024-February 2025.

Pius Mutuku, Ahmed Abade, Maurice Owiny, Zephania Irura, Abdi Roba, Hilary Limo, Amy Herman-Roloff, Naomi Lucchi, Nancy Bowen, Ahmed Fidhow and 2 more

Abstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Mpox and the one health approach.Dialogues in health · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. First-ever imported case of clade Ib Mpox in Senegal.New microbes and new infections · 2026
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pius Mutuku
Ahmed Abade
Maurice Owiny
Zephania Irura
Abdi Roba
Hilary Limo
Amy Herman-Roloff
Naomi Lucchi
Nancy Bowen
Ahmed Fidhow
Daniel Lang'at
Jonas Z Hines

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since July 2024, Kenya has been experiencing an mpox outbreak caused by clade Ib Monkeypox virus (MPXV), a newly recognized variant that has spread from the Democratic Republic of the Congo to multiple countries within and outside of Africa. This report describes the characteristics of laboratory-confirmed clade Ib mpox cases in Kenya during the first 7 months of the outbreak. Among 447 suspected cases during July 2024-February 2025, a total of 48 (10.7%) were confirmed by polymerase chain reaction testing. Most confirmed cases occurred along a highway from the Indian Ocean port in Mombasa to Malaba at the Ugandan border, a transportation corridor that links Kenya to other East and Central African countries. Among the 48 confirmed cases, 27 (56.3%) occurred among persons associated with the transportation corridor, including truck drivers (12; 25.0%), sex workers (eight; 16.7%), and persons employed at or near trucking stopovers (seven; 14.6%). Sexual transmission was suspected in 30 (62.5%) cases, based on the patient's history or locations of the lesions; 11 (22.9%) patients also had HIV infection, one of whom died. Clade Ib MPXV in Kenya appears to be primarily sexually transmitted and concentrated in specific groups at high risk for infection. Public health measures, including vaccination, might be most effective if they focus on these specific groups and geographic areas.

Indexed as

Disease OutbreaksMonkeypox virusMpox, MonkeypoxAdolescentAdultAgedChildChild, PreschoolFemaleHumansKenyaMaleMiddle AgedYoung Adult

Identifiers

PMID40531681
PMCPMC12176102

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.